SCHEMBL1634641

SCHEMBL1634641

COc1ccc(S(=O)(=O)NCC(=O)O)cc1OP(=O)(Oc1cc(S(=O)(=O)NCC(=O)O)ccc1OC)Oc1cc(S(=O)(=O)NCC(=O)O)ccc1OC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
MAPT P10636 1/20 0.54
MEP1B Q16820 1/20 0.51
APEX1 P27695 1/20 0.50
KMT2A Q03164 3/20 0.49
MAPK1 P28482 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HTT P42858 2/20 0.48
LMNA P02545 1/20 0.48
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634074 0.95 L3MBTL1 (0.54) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL1635227 0.92 L3MBTL1 (0.52) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL1634642 0.91 L3MBTL1 (0.55) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL1635482 0.88 L3MBTL1 (0.48) L3MBTL1MAPTKMT2ANPSR1HTT
SCHEMBL1634552 0.79 L3MBTL1 (0.53) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL1634828 0.78 L3MBTL1 (0.53) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL5171144 0.78 KMT2A (0.59) MEP1BKMT2AMAPK1NPSR1HTT
SCHEMBL2941926 0.76 MAPK1 (0.65) KMT2AMAPK1NPSR1HTTLMNA
SCHEMBL1635281 0.76 L3MBTL1 (0.50) L3MBTL1MAPTMEP1BAPEX1KMT2A
SCHEMBL5899490 0.75 KAT6A (0.62) MEP1BKMT2AMAPK1NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP disclosed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP disclosed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 L3MBTL1 2021/4885MAPT 2810/4885MEP1B 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.